Development History_Shanghai Tofflon Bio-reagent Co., Ltd.

2015

2015

Establishment of Shanghai Tofflon Medical Technology Industry Development Co.; Carried out the construction of systematized solutions for macromolecular drugs and cell therapy.

2016

2016

Acquisition of a CAR-T company to focus on cellular drug processes; Establishment of a biological cell laboratory to carry out research into cell culture techniques; Establishment of a GMP demonstration centre for a public service platform for cellular drug conversion; Establishment of a dedicated medium development and production department under the Life Sciences segment; Established medium R＆D and pilot production laboratory to carry out formula research.

2021

2021

Preparation for the establishment of a subsidiary for the development and production of culture media; 2021.04 Establishment of Shanghai Tofflon Bioreagent Co.; 2021.12 Obtaining ISO 9001:2015 quality system certification; We launch systemic medium for macromolecules and cell therapy; International and domestic marketing and sales of our own culture media products.

2022

2022

Breakthrough in technology: CHO, HEK293 series formulation development and production Breakthrough in production capacity: large-scale production line preparation (Hangzhou Pharmaceutical Town) Breakthrough in performance: international supply chain of domestically produced culture media achieved Certification documents: DMF certification filing (CHO,HEK293)

2015

2015

2016

2016

2021

2021

2022

2022

+86 21 64909996-330

139, Duhui Road, Minhang District, Shanghai, China

bioreagent@tofflon.com